RETRACTED: METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells (Retracted article. See vol. 11, 2023)

被引:3
|
作者
Feng, Lili [1 ]
Yan, Qinying [2 ]
Pan, Hui [1 ,3 ]
Shi, Wodong [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Ophthalmol, Sch Med, Shanghai, Peoples R China
[2] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Ophthalmol, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China
基金
中国国家自然科学基金;
关键词
diffuse large B-cell lymphoma; METTL3; NEDD1; the Hedgehog signaling; YTHDF1; SURVIVAL; CONTEXT; PATHWAY;
D O I
10.1002/iid3.789
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
AimDiffuse large B-cell lymphoma (DLBCL) remains the most frequent subpopulation of lymphoma, and N6-methyladenosine (m6A) was implicated in the DLBCL progression. Herein, we sought to decipher the m6A-asociated mechanism of NEDD1 in DLBCL development. MethodsThe NEDD1 expression profile in DLBCL was assessed by quantitative real-time polymerase chain reaction (RT-qPCR) and Western blot. NEDD1 was artificially downregulated or upregulated in DLBCL cells, followed by EdU, Transwell assays and flow cytometry. The Hedgehog pathway activity was assayed by a dual-luciferase assay. The m6A methylation of NEDD1 in DLBCL was assessed by meRIP-qPCR, and the regulatory mechanism of METTL3 on NEDD1 was validated. The LDH assay was conducted to examine the impact of CD8(+) T cells on DLBCL cells. The DLBCL cells were administrated into mice to evaluate the tumorigenic activity and ki-67 activity in tumor tissues. ResultsNEDD1 was overexpressed in DLBCL. Depletion of NEDD1 inhibited the aggressiveness of SU-DHL-8 and OCI-LY1 cells, whereas overexpression of NEDD1 expedited the aggressiveness of SU-DHL-8 and OCI-LY1 cells. METTL3 promoted NEDD1 translation in an m6A-dependent manner via YTHDF1. Depletion of METTL3 inhibited SU-DHL-8 and OCI-LY1 cell activity through regulation of NEDD1. NEDD1 reversed the repressive effect of METTL3 loss on the aggressiveness of SU-DHL-8 and OCI-LY1 cells. NEDD1 activated the Hedgehog signaling to promote immune escape of DLBCL. ConclusionsMETTL3 promotes translation of NEDD1 via YTHDF1-depedndent m6A modification, thereby activating the Hedgehog signaling pathway to promote immune escape of DLBCL cells.
引用
收藏
页数:14
相关论文
共 22 条
  • [1] RETRACTION: METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells (Retraction of Vol 11, art no E789, 2023)
    Feng, L.
    Yan, Q.
    Pan, H.
    Shi, W.
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (05)
  • [2] RETRACTED: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2 (Retracted article. See vol. 26, pg. 4947, 2022)
    Meng, Q. -Z.
    Cong, C. -H.
    Li, X. -J.
    Zhu, F.
    Zhao, X.
    Chen, F. -W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4328 - 4336
  • [3] RETRACTED: MicroRNA-19b inhibits proliferation of gastric cancer cells by targeting B-cell CLL/lymphoma 3 (Retracted article. See vol. 49, 2023)
    Wang, Huan
    Xiong, Mei
    Hu, Yongwu
    Sun, Yusheng
    Ma, Qing
    ONCOLOGY REPORTS, 2016, 36 (04) : 2079 - 2086
  • [4] RETRACTED: Overexpression of miR-222-3p Promotes the Proliferation and Inhibits the Apoptosis of Diffuse Large B-Cell Lymphoma Cells via Suppressing PPP2R2A (Retracted article. See vol. 22, 2023)
    Sun, Shanshan
    Wang, Hui
    Ji, Mingyou
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18 : 1533033819892256
  • [5] RETRACTED: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis (vol 12, 135, 2019) (Retracted article. See vol. 16, 2023)
    Jin, Dan
    Guo, Jiwei
    Wu, Yan
    Du, Jing
    Yang, Lijuan
    Wang, Xiaohong
    Di, Weihua
    Hu, Baoguang
    An, Jiajia
    Kong, Lingqun
    Pan, Lei
    Su, Guoming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [6] METTL3-mediated m6A methylation of C1qA regulates the Rituximab resistance of diffuse large B-cell lymphoma cells
    Li, Junping
    Zhu, Zhigang
    Zhu, Yuan
    Li, Jinqing
    Li, Kangbao
    Zhong, Weijie
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [7] METTL3-mediated m6A methylation of C1qA regulates the Rituximab resistance of diffuse large B-cell lymphoma cells
    Junping Li
    Zhigang Zhu
    Yuan Zhu
    Jinqing Li
    Kangbao Li
    Weijie Zhong
    Cell Death Discovery, 9
  • [8] RETRACTED: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (Retracted article. See vol. 65, pg. 861, 2012)
    de Jong, D.
    Xie, W.
    Rosenwald, A.
    Chhanabhai, M.
    Gaulard, P.
    Klapper, W.
    Lee, A.
    Sander, B.
    Thorns, C.
    Campo, E.
    Molina, T.
    Hagenbeek, A.
    Horning, S.
    Lister, A.
    Raemaekers, J.
    Salles, G.
    Gascoyne, R. D.
    Weller, E.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (02) : 128 - 138
  • [9] RETRACTED: The LMCD1-AS1/miR-526b-3p/OSBPL5 axis promotes cell proliferation, migration and invasion in non-small cell lung cancer (Retracted article. See vol. 23, 2023)
    Hu, Rui
    Yu, Yankai
    Wang, Haining
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [10] RETRACTED: Long non-coding RNA PSMA3-AS1 enhances cell proliferation, migration and invasion by regulating miR-302a-3p/RAB22A in glioma (Retracted article. See vol. 43, 2023)
    Zhou, Li-li
    Zhang, Meng
    Zhang, Yan-zhen
    Sun, Mei-fen
    BIOSCIENCE REPORTS, 2020, 40